Loading...

Proto Labs

WBAG:PRLB
Snowflake Description

Flawless balance sheet with proven track record.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
PRLB
WBAG
$3B
Market Cap
  1. Home
  2. AT
  3. Capital Goods
Company description

Proto Labs, Inc., together with its subsidiaries, operates as an e-commerce driven digital manufacturer of custom parts for prototyping and short-run production worldwide. The last earnings update was 81 days ago. More info.


Add to Portfolio Compare Print
PRLB Share Price and Events
7 Day Returns
-0.5%
WBAG:PRLB
-0.8%
AT Machinery
-1%
AT Market
1 Year Returns
-
WBAG:PRLB
-32.2%
AT Machinery
-7.2%
AT Market
PRLB Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Proto Labs (PRLB) -0.5% 3.3% - - - -
AT Machinery -0.8% -2.2% -23.9% -32.2% -27.8% -29.1%
AT Market -1% 0.6% -7.5% -7.2% 38.4% 26.2%
1 Year Return vs Industry and Market
  • No trading data on PRLB.
  • No trading data on PRLB.
Price Volatility
PRLB
Industry
5yr Volatility vs Market

PRLB Value

 Is Proto Labs undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Proto Labs to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Proto Labs.

WBAG:PRLB Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 6 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 6.8%
Perpetual Growth Rate 10-Year AT Government Bond Rate 0.5%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for WBAG:PRLB
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year AT Govt Bond Rate 0.5%
Equity Risk Premium S&P Global 6%
Machinery Unlevered Beta Simply Wall St/ S&P Global 1.08
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 1.081 (1 + (1- 21%) (0.42%))
1.057
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.06
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 0.51% + (1.057 * 5.96%)
6.81%

Discounted Cash Flow Calculation for WBAG:PRLB using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Proto Labs is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

WBAG:PRLB DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 6.81%)
2020 69.00 Analyst x1 64.60
2021 113.00 Analyst x1 99.05
2022 146.34 Est @ 29.5% 120.10
2023 176.79 Est @ 20.81% 135.84
2024 202.81 Est @ 14.72% 145.90
2025 224.01 Est @ 10.46% 150.88
2026 240.75 Est @ 7.47% 151.82
2027 253.71 Est @ 5.38% 149.79
2028 263.66 Est @ 3.92% 145.74
2029 271.30 Est @ 2.9% 140.41
Present value of next 10 years cash flows $1,304.13
WBAG:PRLB DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= $271.30 × (1 + 0.51%) ÷ (6.81% – 0.51%)
$4,329.25
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $4,329.25 ÷ (1 + 6.81%)10
$2,240.53
WBAG:PRLB Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $1,304.13 + $2,240.53
$3,544.66
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $3,544.66 / 26.85
$132.02
WBAG:PRLB Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in WBAG:PRLB represents 0.90204x of NYSE:PRLB
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.90204x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (USD) x Listing Adjustment Factor
= $ 132.02 x 0.90204
€119.09
Value per share (EUR) From above. €119.09
Current discount Discount to share price of €96.50
= -1 x (€96.50 - €119.09) / €119.09
19%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Proto Labs is available for.
Intrinsic value
19%
Share price is €96.5 vs Future cash flow value of €119.09
Current Discount Checks
For Proto Labs to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Proto Labs's share price is below the future cash flow value, but not at a moderate discount (< 20%).
  • Proto Labs's share price is below the future cash flow value, but not at a substantial discount (< 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Proto Labs's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Proto Labs's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
WBAG:PRLB PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-03-31) in USD $2.74
NYSE:PRLB Share Price ** NYSE (2019-07-19) in USD $106.98
Europe Machinery Industry PE Ratio Median Figure of 187 Publicly-Listed Machinery Companies 15.45x
Austria Market PE Ratio Median Figure of 54 Publicly-Listed Companies 14x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Proto Labs.

WBAG:PRLB PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NYSE:PRLB Share Price ÷ EPS (both in USD)

= 106.98 ÷ 2.74

39.01x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Proto Labs is overvalued based on earnings compared to the Europe Machinery industry average.
  • Proto Labs is overvalued based on earnings compared to the Austria market.
Price based on expected Growth
Does Proto Labs's expected growth come at a high price?
Raw Data
WBAG:PRLB PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 39.01x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 6 Analysts
13%per year
Europe Machinery Industry PEG Ratio Median Figure of 128 Publicly-Listed Machinery Companies 1.41x
Austria Market PEG Ratio Median Figure of 33 Publicly-Listed Companies 1.27x

*Line of best fit is calculated by linear regression .

WBAG:PRLB PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 39.01x ÷ 13%

3x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Proto Labs is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on Proto Labs's assets?
Raw Data
WBAG:PRLB PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-03-31) in USD $20.22
NYSE:PRLB Share Price * NYSE (2019-07-19) in USD $106.98
Austria Machinery Industry PB Ratio Median Figure of 6 Publicly-Listed Machinery Companies 1.62x
Austria Market PB Ratio Median Figure of 62 Publicly-Listed Companies 1.19x
WBAG:PRLB PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NYSE:PRLB Share Price ÷ Book Value per Share (both in USD)

= 106.98 ÷ 20.22

5.29x

* Primary Listing of Proto Labs.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Proto Labs is overvalued based on assets compared to the AT Machinery industry average.
X
Value checks
We assess Proto Labs's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Machinery industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Machinery industry average (and greater than 0)? (1 check)
  5. Proto Labs has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

PRLB Future Performance

 How is Proto Labs expected to perform in the next 1 to 3 years based on estimates from 6 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
13%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Proto Labs expected to grow at an attractive rate?
  • Proto Labs's earnings growth is expected to exceed the low risk savings rate of 0.5%.
Growth vs Market Checks
  • Proto Labs's earnings growth is expected to exceed the Austria market average.
  • Proto Labs's revenue growth is expected to exceed the Austria market average.
Annual Growth Rates Comparison
Raw Data
WBAG:PRLB Future Growth Rates Data Sources
Data Point Source Value (per year)
WBAG:PRLB Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 6 Analysts 13%
WBAG:PRLB Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 6 Analysts 11.3%
Austria Machinery Industry Earnings Growth Rate Market Cap Weighted Average 18.7%
Europe Machinery Industry Revenue Growth Rate Market Cap Weighted Average 3.8%
Austria Market Earnings Growth Rate Market Cap Weighted Average 8.7%
Austria Market Revenue Growth Rate Market Cap Weighted Average 3.1%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
WBAG:PRLB Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 6 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
WBAG:PRLB Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2023-12-31 757 1
2022-12-31 676 1
2021-12-31 613 173 2
2020-12-31 537 140 85 6
2019-12-31 479 131 69 6
WBAG:PRLB Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-03-31 451 115 74
2018-12-31 446 123 77
2018-09-30 427 108 72
2018-06-30 400 102 64
2018-03-31 372 89 58
2017-12-31 344 82 52
2017-09-30 323 78 47
2017-06-30 313 78 46
2017-03-31 306 78 44
2016-12-31 298 77 43
2016-09-30 299 75 45
2016-06-30 289 69 46

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Proto Labs's earnings are expected to grow by 13% yearly, however this is not considered high growth (20% yearly).
  • Proto Labs's revenue is expected to grow by 11.3% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
WBAG:PRLB Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 6 Analyst Estimates (S&P Global) See Below

All data from Proto Labs Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

WBAG:PRLB Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2023-12-31
2022-12-31
2021-12-31
2020-12-31 3.03 3.13 2.96 3.00
2019-12-31 2.51 2.53 2.47 3.00
WBAG:PRLB Past Financials Data
Date (Data in USD Millions) EPS *
2019-03-31 2.74
2018-12-31 2.84
2018-09-30 2.66
2018-06-30 2.38
2018-03-31 2.15
2017-12-31 1.94
2017-09-30 1.76
2017-06-30 1.72
2017-03-31 1.67
2016-12-31 1.62
2016-09-30 1.72
2016-06-30 1.74

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Proto Labs will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Proto Labs's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Austria market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Proto Labs has a total score of 3/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

PRLB Past Performance

  How has Proto Labs performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Proto Labs's growth in the last year to its industry (Machinery).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Proto Labs's year on year earnings growth rate has been positive over the past 5 years.
  • Proto Labs's 1-year earnings growth exceeds its 5-year average (28.5% vs 12.9%)
  • Proto Labs's earnings growth has exceeded the Europe Machinery industry average in the past year (28.5% vs 12.2%).
Earnings and Revenue History
Proto Labs's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Proto Labs Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

WBAG:PRLB Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-03-31 451.30 74.05 122.93 30.08
2018-12-31 445.60 76.59 121.05 28.74
2018-09-30 427.01 71.57 117.96 26.93
2018-06-30 399.68 63.86 112.12 25.35
2018-03-31 372.07 57.63 105.80 24.40
2017-12-31 344.49 51.78 98.06 23.56
2017-09-30 322.67 46.88 89.12 23.06
2017-06-30 312.73 45.64 86.86 23.16
2017-03-31 305.65 44.25 84.56 22.89
2016-12-31 298.06 42.71 82.78 22.39
2016-09-30 299.46 45.33 82.42 21.99
2016-06-30 289.13 45.73 78.77 20.77
2016-03-31 278.14 46.72 73.00 19.35
2015-12-31 264.11 46.51 68.90 18.35
2015-09-30 246.42 44.71 63.33 18.15
2015-06-30 233.15 42.72 58.26 17.95
2015-03-31 222.05 41.99 55.25 17.47
2014-12-31 209.58 41.64 51.27 16.61
2014-09-30 197.56 40.95 47.28 15.38
2014-06-30 184.99 39.44 43.73 13.85
2014-03-31 171.87 37.09 40.40 12.69
2013-12-31 163.11 35.28 38.54 11.86
2013-09-30 152.69 33.17 36.48 10.92
2013-06-30 143.13 31.00 34.51 10.46
2013-03-31 133.33 27.53 32.88 10.11
2012-12-31 125.99 24.03 32.06 9.14
2012-09-30 118.01 18.13 31.92 8.21

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Proto Labs has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Proto Labs used its assets more efficiently than the Europe Machinery industry average last year based on Return on Assets.
  • Proto Labs's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Proto Labs's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Machinery industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Proto Labs has a total score of 4/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

PRLB Health

 How is Proto Labs's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Proto Labs's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Proto Labs is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Proto Labs's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Proto Labs's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Proto Labs has no debt, it does not need to be covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Proto Labs Company Filings, last reported 3 months ago.

WBAG:PRLB Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-03-31 542.80 0.00 120.40
2018-12-31 541.50 0.00 131.80
2018-09-30 531.21 0.00 120.15
2018-06-30 506.25 0.00 120.22
2018-03-31 487.68 0.00 98.56
2017-12-31 461.22 5.00 94.13
2017-09-30 429.84 0.00 172.48
2017-06-30 410.80 0.00 147.47
2017-03-31 392.46 0.00 117.44
2016-12-31 379.83 0.00 108.27
2016-09-30 370.82 0.00 107.25
2016-06-30 356.78 0.00 96.55
2016-03-31 343.71 0.00 89.43
2015-12-31 327.65 0.00 80.85
2015-09-30 314.19 0.00 92.19
2015-06-30 293.99 0.00 87.51
2015-03-31 277.65 0.00 81.61
2014-12-31 265.54 0.00 74.04
2014-09-30 254.32 0.00 58.48
2014-06-30 239.08 0.00 48.11
2014-03-31 224.48 0.00 78.56
2013-12-31 211.64 0.00 79.38
2013-09-30 197.60 0.00 73.03
2013-06-30 183.03 0.00 65.78
2013-03-31 170.63 0.00 63.62
2012-12-31 156.70 0.00 61.90
2012-09-30 140.73 0.00 57.99
  • Proto Labs has no debt.
  • Proto Labs has no debt compared to 5 years ago when it was 0.1%.
  • Proto Labs has no debt, it does not need to be covered by operating cash flow.
  • Proto Labs has no debt, therefore coverage of interest payments is not a concern.
X
Financial health checks
We assess Proto Labs's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Proto Labs has a total score of 6/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

PRLB Dividends

 What is Proto Labs's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Proto Labs dividends. Estimated to be 0% next year.
If you bought €2,000 of Proto Labs shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Proto Labs's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Proto Labs's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
WBAG:PRLB Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 6 Analyst Estimates (S&P Global) See Below
Europe Machinery Industry Average Dividend Yield Market Cap Weighted Average of 144 Stocks 3.1%
Austria Market Average Dividend Yield Market Cap Weighted Average of 51 Stocks 3.6%
Austria Minimum Threshold Dividend Yield 10th Percentile 1%
Austria Bottom 25% Dividend Yield 25th Percentile 1.5%
Austria Top 25% Dividend Yield 75th Percentile 4.6%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

WBAG:PRLB Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2023-12-31
2022-12-31
2021-12-31 0.00 1.00
2020-12-31 0.00 1.00
2019-12-31 0.00 1.00

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Proto Labs has not reported any payouts.
  • Unable to verify if Proto Labs's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Proto Labs's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Proto Labs has not reported any payouts.
Future Payout to shareholders
  • No need to calculate the sustainability of Proto Labs's dividends in 3 years as they are not expected to pay a notable one for Austria.
X
Income/ dividend checks
We assess Proto Labs's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Proto Labs afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Proto Labs has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

PRLB Management

 What is the CEO of Proto Labs's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Vicki Holt
COMPENSATION $3,596,055
AGE 61
TENURE AS CEO 5.4 years
CEO Bio

Ms. Victoria M. Holt, also known as Vicki, has been the Chief Executive Officer and President of Proto Labs, Inc. since February 6, 2014. Ms. Holt serves as Chief Executive Officer and President of Proto Labs, Ltd. She has been the Chief Executive Officer and President of Spartech Plastics, LLC since September 8, 2010. She has been Chief Executive Officer and President of Spartech Polycom, Inc., since September 2010. She has more than 30 years of experience in leadership roles with Global Fortune 500 companies across a broad range of manufacturing, chemical and materials industries. She served as the Chief Executive Officer and President of Spartech Corp. from September 8, 2010 to 2013. Ms. Holt served as Senior Vice President of Glass & Fiber Glass of PPG Industries Inc. from May 1, 2005 to September 8, 2010. She was responsible for the fiber glass, flat glass and automotive OEM glass business units. She joined PPG in January 2003 from Solutia Inc., where she served as Vice President and General Manager of Performance Films. She served as Business Director of Acrilan Business Unit of Monsanto Company from 1996 to 1997 as well as Assistant to Monsanto's Chief Executive Officer from 1995 to 1996. She began her career at Monsanto in 1979 selling commodity and specialty chemicals and served as Vice President and General Manager of Acrilan, a global acrylic fiber business that is part of Solutia, the chemicals business spun off by Monsanto since 1997. Since 1998, she served as Vice President of Saflex. She has been a Director of Watlow Electric Manufacturing Company since June 4, 2012. She has been an Independent Director of Waste Management, Inc. since January 28, 2013. She has been a Director of Spartech Plastics, LLC (alternate name, Spartech Plastics Inc.) and Spartech Polycom, Inc. since 2005. She has been a Director of Proto Labs, Inc. since 2014. She served as a Director of Spartech Corp. since September 22, 2005 until 2013. Ms. Holt graduated with a BS in Chemistry from Duke University and MBA in Finance from Pace University.

CEO Compensation
  • Vicki's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Vicki's remuneration is higher than average for companies of similar size in Austria.
Management Team Tenure

Average tenure and age of the Proto Labs management team in years:

4.4
Average Tenure
50.5
Average Age
  • The tenure for the Proto Labs management team is about average.
Management Team

Vicki Holt

TITLE
President
COMPENSATION
$4M
AGE
61
TENURE
5.4 yrs

John Way

TITLE
CFO & Executive VP of Development
COMPENSATION
$1M
AGE
46
TENURE
4.6 yrs

Rich Baker

TITLE
Chief Technology Officer
COMPENSATION
$1M
AGE
51
TENURE
3.2 yrs

David Fein

TITLE
Chief Revenue Officer
COMPENSATION
$1M
AGE
50
TENURE
2.6 yrs

Dan Schumacher

TITLE
Director of Investor Relations and FP&A

Bill Dietrick

TITLE
Vice President of Global Marketing
AGE
63
TENURE
11.2 yrs

Renee Conklin

TITLE
Vice President of Global Human Resources
TENURE
5 yrs

Bjoern Klaas

TITLE
VP, GM and MD of Europe
AGE
49
TENURE
1.6 yrs

Jason Frankman

TITLE
Controller & Secretary
TENURE
4.3 yrs
Board of Directors Tenure

Average tenure and age of the Proto Labs board of directors in years:

3.3
Average Tenure
61
Average Age
  • The tenure for the Proto Labs board of directors is about average.
Board of Directors

Sven Wehrwein

TITLE
Chairman & Lead Independent Director
COMPENSATION
$240K
AGE
68
TENURE
2.2 yrs

Vicki Holt

TITLE
President
COMPENSATION
$4M
AGE
61
TENURE
5.5 yrs

Rainer Gawlick

TITLE
Director
COMPENSATION
$198K
AGE
51
TENURE
10.8 yrs

John Goodman

TITLE
Director
COMPENSATION
$193K
AGE
59
TENURE
18.5 yrs

Donald Krantz

TITLE
Director
COMPENSATION
$175K
AGE
64
TENURE
2.2 yrs

Archie Black

TITLE
Director
COMPENSATION
$181K
AGE
57
TENURE
3.3 yrs

Sujeet Chand

TITLE
Director
COMPENSATION
$185K
AGE
61
TENURE
2.2 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
X
Management checks
We assess Proto Labs's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Proto Labs has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

PRLB News

Simply Wall St News

PRLB Company Info

Description

Proto Labs, Inc., together with its subsidiaries, operates as an e-commerce driven digital manufacturer of custom parts for prototyping and short-run production worldwide. It utilizes injection molding, computer numerical control machining, three-dimensional (3D) printing, and sheet metal fabrication to manufacture custom parts for developers and engineers who use 3D computer-aided design software to design products across a range of end markets. The company was founded in 1999 and is headquartered in Maple Plain, Minnesota.

Details
Name: Proto Labs, Inc.
PRLB
Exchange: WBAG
Founded: 1999
$2,559,755,650
26,848,544
Website: http://www.protolabs.com
Address: Proto Labs, Inc.
5540 Pioneer Creek Drive,
Maple Plain,
Minnesota, 55359,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NYSE PRLB Common Stock New York Stock Exchange US USD 24. Feb 2012
DB PRZ Common Stock Deutsche Boerse AG DE EUR 24. Feb 2012
LSE 0KRR Common Stock London Stock Exchange GB USD 24. Feb 2012
WBAG PRLB Common Stock Wiener Boerse AG AT EUR 24. Feb 2012
Number of employees
Current staff
Staff numbers
2,487
Proto Labs employees.
Industry
Industrial Machinery
Capital Goods
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/07/20 23:29
End of day share price update: 2019/07/19 00:00
Last estimates confirmation: 2019/07/03
Last earnings filing: 2019/04/30
Last earnings reported: 2019/03/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.